Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET® System for Glycemic Improvement in Patients With Inadequately Controlled Type 2 Diabetes and Obesity

NCT04101669 is registered in ClinicalTrials.gov with Morphic Medical Inc. as lead sponsor.

NCT NCT04101669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04101669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the RESET® System for Glycemic Improvement in Patients With Inadequately Controlled Type 2 Diabetes and Obesity
Lead sponsor
Morphic Medical Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
September 9, 2019
Completion date
September 30, 2029
Enrollment
264 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type2, obesity